Keystone Symposium on Respiratory Viruses of Animals Causing Disease in Humans

[KeystoneSymposia]

Respiratory Viruses of Animals Causing Disease in Humans

In collaboration with Agency for Science, Technology and Research (A*STAR), Singapore

Organizers: Stanley A. Plotkin, Albert D.M.E. Osterhaus and Martin L. Hibberd

December 10 - 15, 2006

Swissotel The Stamford/Biopolis ? Singapore, Singapore

http://www.keystonesymposia.org/singapore

[Mingus]

Re: Keytone Symposium on Respiratory Viruses of Animals Causing Disease in Humans

Will be there...

Khaw Boon Wan, Minister of Health, Singapore

Albert D.M.E. Osterhaus, Erasmus MC, Rotterdam, Holland
Animals and Human Respiratory Virus Infections

Roy M. Anderson, Imperial College, St. Mary's Medical School, London, UK
Dynamics of Respiratory Virus Infection

David L. Smith?, National Institutes of Health, Bethesda, USA
Dynamics of Vector Transmission

Derek Smith, Cambridge University, Cambridge, UK
Evolution of Influenza Viruses

Scott Dowell, Global Health CDC, Atlanta, USA
The Epidemiology of Human Infections with Influenza A (H5N1)

Robert G. Webster, St. Jude Children's Research Hospital, USA
The Reservoirs of Avian Influenza Viruses

Ming Liao, South China Agricultural University, China
Genetic Characterization of Influenza A (H5N1) Viruses in Birds

Chang Won Lee, United States Department of Agriculture, Athens, USA
Low and high pathogenicity avian influenza in Korea

Menno de Jong, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam
Pathogenesis of Influenza A (H5N1) H5N1 in Humans

Jacqueline M. Katz, Centers for Disease Control and Prevention, Atlanta, USA
Epidemiology of Influenza A (H5N1) in Animals and Humans

Ron A.M. Fouchier, Erasmus MC, Rotterdam, Holland
Adaptation of Influenza A (H5N1) to Mammals

Guan Yi, Hong Kong University
Influenza A (H5N1) Virus in Asian Birds

Inger Damon, Centers for Disease Control and Prevention, Atlanta, USA
Monkeypox in Humans

Koert Stittelaar, Erasmus MC, Rotterdam, Holland
Monkeypox as a Model for Smallpox

Malik Peiris, University of Hong Kong, China
Pathogenesis and Origin of SARS

Martin L. Hibberd , Genome Institute of Singapore
Host Response to SARS

Tak-sun Ignatius Yu, The Chinese University of Hong Kong, China
Evidence on the Airborne Transmission of SARS

Jan H. ter Meulen, Crucell BV, Leiden, Holland
Monoclonal Antibodies to Treat SARS

Joe McCormack, University of Queensland, South Brisbane, Australia
Hendra virus in animals and humans

Jay W. Hooper, USAMRIID
Hantaviruses

Paul A. Rota, Centers for Disease Control, Atlanta, USA
Paramyxoviruses

Jian-Feng He?, Center for Disease Control and Prevention of Guangdong Province, China
Animal Reservoirs of Human Virus Infections

Peter M. Palese, Mount Sinai School of Medicine, New York, USA
Reverse Genetics of Influenza Viruses for Use in Vaccines

Yoshihiro Kawaoka, University of Wisconsin-Madison, USA
Influenza A (H5N1) Vaccines

Kanta Subbarao, National Institutes of Health, Bethesda, USA
Vaccines Against SARS Virus

* Stanley A. Plotkin, Sanofi Pasteur, Pennsylvania, USA
Inactivated Influenza A (H5N1) Vaccine

Rino Rappuoli, Chiron Srl, Siena, Italy
SARS and H5N1 Vaccines

James Young , MedImmune, Gaithersburg, USA
Live Influenza A (H5N1) Vaccine

Margaret Chen?, World Health Organization, Geneva, Switzerland
Plans for Control of Influenza A (H5N1)

Alejandro Schudel, Office Internatinal Des Epizooties, Paris, France
Vaccination of Animals to Control of Zoonotic Infections

Andrea Gambotto, University of Pittsburgh

Hildegund C.J. Ertl, Wistar Institute, Philadelphia, USA
Non-Human Adenoviruses

Peter Daszak, Consortium for Conservation Medicine, New York, USA
Ecological Control of Viral Zoonoses